Aug 26, 2026
Innovating ADCs with Dual Targeting and Smarter Delivery
29 minutes
Episodes
Ordered by publication date.
Aug 19, 2026
Targeting the Brain’s Immune System in Alzheimer’s Disease
34 minutes
Aug 12, 2026
How Gilead Is Building Durable Oncology and Immunology Franchises
38 minutes
Aug 5, 2026
Protecting the Brain After Stroke
29 minutes
Jul 29, 2026
Turning the Thymus into an Engine of Immune Tolerance in T1D and Beyond
38 minutes
Jul 22, 2026
Unlocking Major Targets with Mini Proteins
25 minutes
Jul 15, 2026
Addressing a Data Problem to Enable AI-Drug Discovery
41 minutes
Jul 8, 2026
Turning Multi Specific Antibody Design into an Engineering Discipline with AI
29 minutes
Jul 1, 2026
Addressing the Treatment Gap in Ischemic Stroke
30 minutes
Jun 24, 2026
A Pipeline in a Product that Reimagines Control of Inflammation
24 minutes
Jun 17, 2026
Building a Genetics Engine to Crack the Target Bottleneck
52 minutes
Jun 10, 2026
Stopping Shape-Shifting Tumors with a First-in-Class Epigenetic Drug
28 minutes
Jun 3, 2026
Rewriting the Rules of Antibody Drug Design
37 minutes
May 27, 2026
Mapping Cellular Stress Biology to Tackle Undruggable Targets
30 minutes
May 20, 2026
Turning Abandoned Drugs into Breakthroughs
30 minutes
More related podcasts
Other podcasts in Business.